Latest News

ICAL member, Ali Sadeghi-Naini, advances research in predicting cancer treatment outcomes

Professor Ali Sadeghi-Naini has developed a quantitative MRI biomarker that is capable of predicting the success of stereotactic radiotherapy (SRT) as a cancer treatment strategy. This capability will prove monumental in improving the standard of care available to any patient.

For more information, please see the link below!